Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

Sunscreen Myths: How Evidence Morphed Into Skepticism

Arturo Loaiza-Bonilla, MD, MSEd, explores how confusing and incomplete information on sunscreen safety can lead to misinterpretation and misinformation.

How to Mange Benign Prostatic Hypertrophy in Primary Care

Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy.

For Everyday Shoulder Pain, Less Treatment Is Often More

Most patients with a nontraumatic sore shoulder in primary care can be managed with watchful waiting and symptom relief.

Regular Physical Exercise Tied to Lower Mental Disorder Risk

A prospective study shows that lower levels of physical exercise are consistently associated with a higher risk for common mental disorders in students pursuing higher education.

Hormonal Contraception Not Linked to Flare Risk in UC

Exposure to hormonal contraception is not linked to an increased risk for recurrent flares or cumulative systemic inflammatory burden in female individuals with ulcerative colitis.

Are Pediatricians Following Newborn Jaundice Guidelines?

The American Academy of Pediatrics changed its guidelines in 2022, but a new study suggests pediatricians may not be consistently applying the updated guidance.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Arturo Loaiza-Bonilla, MD, MSEd, explores how confusing and incomplete information on sunscreen safety can lead to misinterpretation and misinformation.

Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy.

Most patients with a nontraumatic sore shoulder in primary care can be managed with watchful waiting and symptom relief.

A prospective study shows that lower levels of physical exercise are consistently associated with a higher risk for common mental disorders in students pursuing higher education.

Exposure to hormonal contraception is not linked to an increased risk for recurrent flares or cumulative systemic inflammatory burden in female individuals with ulcerative colitis.

The American Academy of Pediatrics changed its guidelines in 2022, but a new study suggests pediatricians may not be consistently applying the updated guidance.

News All Time

Menopausal Hormone Therapy May Cut Costs, Improve Health

An analysis finds that menopausal hormone therapy could save thousands of dollars per patient while improving quality of life and reducing cardiovascular disease and deaths.

Real-Life Walking Speed Can Track MS Progression

Wearable accelerometer-based real-life walking speed monitoring can track disability progression earlier and more often than conventional tests in primary progressive multiple sclerosis.

Autism Prevalence Rising Among School-Aged Kids in England

The prevalence of autism continues to rise among school-aged children and young people in England, an analysis of data from 2016 to 2024 shows.

Cannabis Use Linked to Earlier Psychosis Onset

Cannabis users experience psychosis onset 2.5 years earlier on average compared with non-users, a meta-analysis shows.

Radiation in Pancreatic Cancer: ASTRO Updates Its Guidance

The new guidance strengthens radiation therapy recommendations in pancreatic cancer, providing an update to the 2019 guidance.

How Primary Care Physicians Can Support Addiction Recovery

Rural clinicians provide addiction care despite limited services, long travel distances, and gaps in treatment access that can make ongoing support difficult for patients.

Vaccines Saved Millions: The Success That Became Invisible

Declining vaccination coverage and rapidly spreading misinformation contribute to renewed outbreaks of diseases once controlled through widespread immunization.

Physical Activity and Dementia: A Work-Leisure Divide

Staying active during leisure time is linked to a lower risk for dementia, whereas physical activity on the job showed the opposite pattern.

County-Level Medical Debt Tied to Poorer Cancer Survival

Americans living in areas mired in medical debt have later cancer diagnoses and lower survival rates.

The Study-Backed Anxiety Risk Doctors Rarely Recognize

Decades of research show that joint hypermobility, which affects 10%-15% of the population, increases the risk for anxiety and other mental health issues — yet the link remains largely unacknowledged.

Shingles in Young Australians Prompts Vaccination Discussion

The increasing number of younger patients with shingles has prompted debate about expanding free vaccination eligibility.

Fostemsavir Shows Promise in Multidrug-Resistant HIV

Fostemsavir is associated with maintained viral suppression in many heavily treated patients with multidrug-resistant HIV.

Oseltamivir May Cut ICU Admission Risk in Kids With Flu

Children hospitalized with influenza who receive oseltamivir have a lower risk for ICU admissions and shorter hospital stays than those who do not receive the treatment.

Early CF Therapy Improves Olfaction in Young Children

Young children with cystic fibrosis experience improvements in olfactory function and odor identification after 1 year of elexacaftor-tezacaftor-ivacaftor therapy.

ESC 2026: Clinical Trials That Could Change Practice

Which ESC 2026 trials matter most? An expert preview singles out the studies most likely to open new therapeutic avenues or challenge current practice.

Microbiome ‘Leak’ From Mouth to Gut Can Flag GI Cancer

Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal cancers with greater accuracy than conventional stool testing.

Recommended News For You

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Novel Psychedelic Promising on Resistant Depression

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

New imaging guidelines for head and neck cancers, a step toward practice change

Recommended Articles For You

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care? 

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape 

Neonatal Hematopoietic Transition and Blood Cell Maturation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Independent Risk Factors for "Deaths of Despair" Found.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

4.

Infection Burden High With Myeloma T-Cell Therapies

5.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

1.

Genomic Control of Erythropoietic Stem Cell Renewal

2.

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies

3.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

4.

Clonal Hematopoiesis as a Mechanism of Age-Related Disease

5.

Transformative Insights in Oncology in Daily Practice

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Innovations in Hematology

2.

Case-Based Learning: Oncology

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot